Epleronone reduces atrial fibrillation, study suggests
Sunday, May 22, 2011 - 14:30
in Health & Medicine
The aldosterone antagonist eplerenone significantly reduced the development of new onset atrial fibrillation and flutter in patients with class 2 heart failure, concludes a sub-analysis of the EMPHASIS-HF trial.